Zum Hauptinhalt springen
Nicht aus der Schweiz? Besuchen Sie lehmanns.de

ATTD 2011 Year Book (eBook)

Advanced Technologies and Treatments for Diabetes
eBook Download: PDF
2012 | 3. Auflage
John Wiley & Sons (Verlag)
978-1-118-32152-2 (ISBN)

Lese- und Medienproben

ATTD 2011 Year Book - Moshe Phillip, Tadej Battelino
Systemvoraussetzungen
65,99 inkl. MwSt
(CHF 64,45)
Der eBook-Verkauf erfolgt durch die Lehmanns Media GmbH (Berlin) zum Preis in Euro inkl. MwSt.
  • Download sofort lieferbar
  • Zahlungsarten anzeigen
The traditional agents for controlling the levels of glucose in the blood remain important therapies but they have their downside from the point of view of tolerability and side effects. Moreover, they appear not to be able to counter the natural history deterioration of the disease in terms of the onset of diabetic-related complications.

Recent years have seen an influx of new treatment therapies and technologies aimed at achieving better glycaemic control for diabetic patients such as liraglutide (Novo Nordisk) and saxagliptin (BMS/Astra-Zeneca) and insulin pumps, away from the more traditional therapies used (classic insulin therapy, oral hypoglycaemics).

This book outlines these new technologies/treatments by collating the best journal articles published in the last year, and providing expert analysis on each one.

Advanced Technologies and Treatment for Diabetes 3E brings together and critically analyses the last year's most important articles published in the world's leading medical journals on this topic. Chapters are focused on the most current hot topic areas such as: new methods of insulin delivery; internet and IT use in treatment of diabetes; bariatric surgery & diabetes; and immunotherapy for type 1 diabetes. 

 Each chapter includes abstracts of the published articles, scientific conclusions made, as well as annotations and a comments and analysis section from the relevant chapter editor, each of which being a well-known expert in the field.

All researchers in the fields of diabetes, endocrinology and metabolism will find this book extremely useful, as will diabetes technology developers, and specialist endocrinologists involved with the care of diabetic patients.



Prof. Moshe Phillip, Director, The Jesse Z. and Sara Lea Shafer Institute for Endocrinology and Diabetes, National Center for Childhood Diabetes, Schneider Children's Medical Center of Israel.
Vice Dean for Research and Development, Sackler Faculty of Medicine, Tel-Aviv University, Israel.

Prof. Dr. Tadej Battelino, Head of Department of Pediatric Endocrinology, Diabetes and Metabolism , University Children's Hospital , Ljubljana, Slovenia.
Tadej Battelino is professor of pediatrics at the Ljubljana Medical Faculty, and head of pediatric endocrinology, diabetes and metabolism at the University Children's Hospital Ljubljana, Slovenia. He has participated as principal investigator in the CPT trial sponsored by the European Association for the Study of Diabetes, and is involved in many other international clinical and basic research projects. He has published more than 180 papers, of which 51 are published in SCI listed international journals, and is a member of many international societies, including ESPE, EASD, ISPAD. He has been an invited lecturer in Vienna and Tel Aviv Universities, and at many international meetings and symposia.

Prof. Moshe Phillip, Director, The Jesse Z. and Sara Lea Shafer Institute for Endocrinology and Diabetes, National Center for Childhood Diabetes, Schneider Children's Medical Center of Israel. Vice Dean for Research and Development, Sackler Faculty of Medicine, Tel-Aviv University, Israel. Prof. Dr. Tadej Battelino, Head of Department of Pediatric Endocrinology, Diabetes and Metabolism , University Children's Hospital , Ljubljana, Slovenia. Tadej Battelino is professor of pediatrics at the Ljubljana Medical Faculty, and head of pediatric endocrinology, diabetes and metabolism at the University Children's Hospital Ljubljana, Slovenia. He has participated as principal investigator in the CPT trial sponsored by the European Association for the Study of Diabetes, and is involved in many other international clinical and basic research projects. He has published more than 180 papers, of which 51 are published in SCI listed international journals, and is a member of many international societies, including ESPE, EASD, ISPAD. He has been an invited lecturer in Vienna and Tel Aviv Universities, and at many international meetings and symposia.

ATTD 2011 Yearbook 3
Contents 7
List of Contributors 9
Preface 19
CHAPTER 1 Self-Monitoring of Blood Glucose 21
CHAPTER 2 Continuous Glucose Monitoring in 2011 41
CHAPTER 3 Insulin Pumps 62
CHAPTER 4 Closing the Loop 76
CHAPTER 5 New Insulins and Insulin Therapy 103
CHAPTER 6 New Ways of Insulin Delivery 116
CHAPTER 7 Using Health Information Technology to Prevent and Treat Diabetes 129
CHAPTER 8 Technology and Pregnancy 156
CHAPTER 9 Type 1 Diabetes Mellitus: Immune Intervention 177
CHAPTER 10 Advances in Exercise, Physical Activity and Diabetes Mellitus 194
CHAPTER 11 Diabetes Technology and Treatment in the Paediatric Age Group 223
CHAPTER 12 Diabetes Technology and the Human Factor 245
CHAPTER 13 New Medications for the Treatment of Diabetes 263
Index 291

Erscheint lt. Verlag 14.2.2012
Sprache englisch
Themenwelt Sachbuch/Ratgeber Gesundheit / Leben / Psychologie
Medizinische Fachgebiete Innere Medizin Diabetologie
Medizinische Fachgebiete Innere Medizin Endokrinologie
Studium 1. Studienabschnitt (Vorklinik) Biochemie / Molekularbiologie
Schlagworte Blood Glucose • continuous • contributors • Danne • Delivery • Diabetes • endocrinology • Endokrinologie • Eran • Glucose • Health • heinemann • Hirsch • immune intervention • Information • Insulin • List • luttechnology • Medical Science • Medizin • mellitus • New • new ways • Physical • Selfmonitoring • Skyler • Treat • Type
ISBN-10 1-118-32152-9 / 1118321529
ISBN-13 978-1-118-32152-2 / 9781118321522
Informationen gemäß Produktsicherheitsverordnung (GPSR)
Haben Sie eine Frage zum Produkt?
PDFPDF (Adobe DRM)

Kopierschutz: Adobe-DRM
Adobe-DRM ist ein Kopierschutz, der das eBook vor Mißbrauch schützen soll. Dabei wird das eBook bereits beim Download auf Ihre persönliche Adobe-ID autorisiert. Lesen können Sie das eBook dann nur auf den Geräten, welche ebenfalls auf Ihre Adobe-ID registriert sind.
Details zum Adobe-DRM

Dateiformat: PDF (Portable Document Format)
Mit einem festen Seiten­layout eignet sich die PDF besonders für Fach­bücher mit Spalten, Tabellen und Abbild­ungen. Eine PDF kann auf fast allen Geräten ange­zeigt werden, ist aber für kleine Displays (Smart­phone, eReader) nur einge­schränkt geeignet.

Systemvoraussetzungen:
PC/Mac: Mit einem PC oder Mac können Sie dieses eBook lesen. Sie benötigen eine Adobe-ID und die Software Adobe Digital Editions (kostenlos). Von der Benutzung der OverDrive Media Console raten wir Ihnen ab. Erfahrungsgemäß treten hier gehäuft Probleme mit dem Adobe DRM auf.
eReader: Dieses eBook kann mit (fast) allen eBook-Readern gelesen werden. Mit dem amazon-Kindle ist es aber nicht kompatibel.
Smartphone/Tablet: Egal ob Apple oder Android, dieses eBook können Sie lesen. Sie benötigen eine Adobe-ID sowie eine kostenlose App.
Geräteliste und zusätzliche Hinweise

Buying eBooks from abroad
For tax law reasons we can sell eBooks just within Germany and Switzerland. Regrettably we cannot fulfill eBook-orders from other countries.

Mehr entdecken
aus dem Bereich